InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: Skiluc post# 70759

Saturday, 07/03/2021 11:47:07 AM

Saturday, July 03, 2021 11:47:07 AM

Post# of 118366
Explosive Growth Straight Ahead! Be Prepared!

Between NOW and going Pink Current within weeks we can expect strong momentum moving in that will send the PPS to new 52 Week highs....there will be MANY!!

Post-Pink Current...ALL STOPPERS PULL OUT!!! FULL IGNITION!!!

Dozens of brokerage platforms immediately become available to buy RGBP worldwide! i.e. the "investment pool" suddenly changes from a pond to an ocean!

I fully expect a PPS North of $1.00 in the near term wake of Post Pink Current and I believe this is a conservative estimate although it could be higher, and this is ONLY an opinion that I believe is by far a reasonable one.

ENZ*C hit nearly $1 within 19 trading days of going Pink Current despite it having only 1 Patent with no licensing arrangements, no partnerships, not on the verge of entering clinical trials, and no prospect of generating revenues. There's no comparison by far to RGBP's intrinsic value tied to its extensive Multi-Billion Dollar Patent portfolio and current Market position.

20/20

Strong fundamental changes have recently set in for RGBP significantly contributing to its evolution and there will be many more to come.

Recently becoming a revenue generating Bio-Pharma that has successfully licensed 1 of its 20+ Patents, each representing "Disruptive Biotechnology" and each with a $$Billion Dollar market capacity, is just one new development for RGBP now in play.

The near term transition of this new development is RGBP's Candidate Drug Patent NR2F6 for treating pancreatic & colon cancer soon to enter Phase-1 Clinical Trials.

https://www.stocktitan.net/news/ONPH/oncology-pharma-inc-is-entering-into-the-next-phase-of-its-growth-msgem1hjj0hb.html

This development substantially strengthens RGBP's Market Capacity profile marking it as a strong candidate for a Big Pharma Buy Out or Merger-Acquisition that is very common for a Bio-Pharma Company our size and no doubt Koos is aware of this due to him filing the 8K this past April that protects against a Hostile Take Over. IMO, He's likely going to need it!

This is an evolving Bio-Pharma presently in its embryonic stages of development that begins with "PATENT DISCOVERY-THE SCIENCE OF IT ALL", just like ANY Big Pharma on the market today was at one time that also went through the exact same evolution. For those who didn't know this now you do and this is a qualified clinical trials M.D. perspective!

There are very few IF ANY developmental stage Bio-Pharmas in existence on any Stock Exchange that have anywhere close to what RGBP has, and if so, I'd like to know who they are so I can invest in them!

Best wishes to all, and again the above is a personal perspective and opinion only but with professional industry experience insight.

Be well and prosper...